Study: Combination therapy improves retinoblastoma outcome
LOS ANGELES, April 15 — Researchers found a combination of chemotherapy and a protein inhibitor improves the outcome of children with retinoblastoma, according to a recent study. Inhibiting the protein YM155, which prevents the process of cell death, made chemotherapy more effective against cancer cells in the lab and when ... Read More »